Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
08 2022
Historique:
revised: 10 05 2022
received: 14 04 2022
accepted: 16 05 2022
pubmed: 27 5 2022
medline: 9 7 2022
entrez: 26 5 2022
Statut: ppublish

Résumé

Biallelic variants of the gene encoding for the zinc-finger protein 142 (ZNF142) have recently been associated with intellectual disability (ID), speech impairment, seizures, and movement disorders in nine individuals from five families. In this study, we obtained phenotype and genotype information of 26 further individuals from 16 families. Among the 27 different ZNF142 variants identified in the total of 35 individuals only four were missense. Missense variants may give a milder phenotype by changing the local structure of ZF motifs as suggested by protein modeling; but this correlation should be validated in larger cohorts and pathogenicity of the missense variants should be investigated with functional studies. Clinical features of the 35 individuals suggest that biallelic ZNF142 variants lead to a syndromic neurodevelopmental disorder with mild to moderate ID, varying degrees of delay in language and gross motor development, early onset seizures, hypotonia, behavioral features, movement disorders, and facial dysmorphism. The differences in symptom frequencies observed in the unpublished individuals compared to those of published, and recognition of previously underemphasized facial features are likely to be due to the small sizes of the previous cohorts, which underlines the importance of larger cohorts for the phenotype descriptions of rare genetic disorders.

Identifiants

pubmed: 35616059
doi: 10.1111/cge.14165
pmc: PMC9546172
doi:

Substances chimiques

Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-109

Subventions

Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S005021/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT093205MA
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT104033AIA
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Références

Nat Genet. 2004 Oct;36(10):1053-5
pubmed: 15338008
Am J Hum Genet. 2003 Dec;73(6):1341-54
pubmed: 14628291
Genome Res. 2006 May;16(5):669-77
pubmed: 16606702
J Hum Genet. 2022 Mar;67(3):169-173
pubmed: 34531528
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891
pubmed: 33137190
Am J Med Genet B Neuropsychiatr Genet. 2016 Apr;171B(3):333-41
pubmed: 26823146
Genet Med. 2019 Nov;21(11):2532-2542
pubmed: 31036918
J Med Genet. 2004 May;41(5):394-9
pubmed: 15121780
Trends Mol Med. 2006 Jul;12(7):306-16
pubmed: 16782405
Front Neuroanat. 2016 Oct 26;10:86
pubmed: 27833533
Stem Cells. 2009 Jul;27(7):1643-53
pubmed: 19544452
PLoS Genet. 2012;8(4):e1002635
pubmed: 22511880
Cell Death Discov. 2017 Nov 13;3:17071
pubmed: 29152378
Eur J Med Genet. 2018 Dec;61(12):783-789
pubmed: 30391508
Nucleic Acids Res. 2014 Aug;42(14):8928-38
pubmed: 25013167
Schizophr Res. 2001 Dec 1;52(3):161-5
pubmed: 11705709
PLoS One. 2012;7(10):e47481
pubmed: 23071813
Genome Med. 2016 Dec 13;8(1):131
pubmed: 27964749
PLoS One. 2014 Nov 18;9(11):e112687
pubmed: 25405613
Mol Cell. 2017 Jun 1;66(5):711-720.e3
pubmed: 28529057
Eur J Hum Genet. 2012 Aug;20(8):852-6
pubmed: 22378287
Am J Hum Genet. 2016 Aug 4;99(2):253-74
pubmed: 27453576
Am J Hum Genet. 2006 Feb;78(2):265-78
pubmed: 16385466
PLoS One. 2010 Dec 08;5(12):e15082
pubmed: 21170338
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Cell. 2018 Mar 22;173(1):221-233.e12
pubmed: 29551271
Gene. 2012 Sep 1;505(2):384-7
pubmed: 22634100
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Genome Biol. 2003;4(10):231
pubmed: 14519192
Ann Hum Genet. 2002 Nov;66(Pt 5-6):331-42
pubmed: 12485467
Front Neurol. 2020 Feb 14;11:32
pubmed: 32117005
Hum Mol Genet. 2001 Oct 1;10(20):2233-42
pubmed: 11673406
Clin Genet. 2022 Aug;102(2):98-109
pubmed: 35616059
Stem Cell Res Ther. 2011 Apr 27;2(2):20
pubmed: 21539723
J Med Genet. 2022 Mar;59(3):262-269
pubmed: 33397746

Auteurs

Maria B Christensen (MB)

Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.

Amanda M Levy (AM)

Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.

Nazanin A Mohammadi (NA)

Department of Epilepsy Genetics and Personalized Treatment, The Danish Epilepsy Centre, Dianalund, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Marcello Niceta (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.

Rauan Kaiyrzhanov (R)

Department of Neuromuscular Disorders, University College London Institute of Neurology, London, UK.

Maria Lisa Dentici (ML)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
Medical Genetics Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Chadi Al Alam (C)

Pediatric Neurology department, American center for Psychiatry and Neurology, Al Ain, United Arab Emirates.
Pediatric Neurology department, Haykel Hospital, El Koura, Lebanon.

Viola Alesi (V)

Translational Cytogenomics Research Unit, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.

Valérie Benoit (V)

IPG, Centre for Human Genetics, Charleroi, Belgium.

Kailash P Bhatia (KP)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.

Tatjana Bierhals (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian M Boßelmann (CM)

Department of Neurology and Epileptology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Julien Buratti (J)

Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.

Bert Callewaert (B)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Berten Ceulemans (B)

Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

Perrine Charles (P)

Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.

Matthias De Wachter (M)

Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

Mohammadreza Dehghani (M)

Medical Genetics Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Erika D'haenens (E)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Martine Doco-Fenzy (M)

SFR CAP SANTE, HMB2 CHU Reims, Reims, France.
CHU de Nantes, service de génétique médicale, Nantes, France.

Michaela Geßner (M)

KfH-Board of Trustees for Dialysis and Kidney Transplantation (KfH-Kuratorium für Dialyse und Nierentransplantation e.V.), Neu Isenburg, Germany.

Cyrielle Gobert (C)

Neuropediatric department, Centre Hospitalier Neurologique William Lennox, Ottignies, Belgium.

Ulviyya Guliyeva (U)

Department of Pediatrics, MediClub Hospital, Baku, Azerbaijan.

Tobias B Haack (TB)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.

Trine B Hammer (TB)

Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Epilepsy Genetics and Personalized Treatment, The Danish Epilepsy Centre, Dianalund, Denmark.

Tilman Heinrich (T)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
MVZ Humangenetik und Molekularpathologie GmbH, Rostock, Germany.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Theresia Herget (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ute Hoffmann (U)

St. Franziskus-Hospital, Münster, Germany.

Judit Horvath (J)

Institute of Human Genetics, University of Münster, Münster, Germany.

Henry Houlden (H)

Department of Neuromuscular Disorders, University College London Institute of Neurology, London, UK.

Boris Keren (B)

Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.

Christina Kresge (C)

Department of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Candy Kumps (C)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Damien Lederer (D)

IPG, Centre for Human Genetics, Charleroi, Belgium.

Alban Lermine (A)

LBBMS SeqOIA, AP-HP, Paris, France.

Francesca Magrinelli (F)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.

Reza Maroofian (R)

Department of Neuromuscular Disorders, University College London Institute of Neurology, London, UK.

Mohammad Yahya Vahidi Mehrjardi (MY)

Medical Genetics Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Mahdiyeh Moudi (M)

Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Amelie J Müller (AJ)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Anna J Oostra (AJ)

Neuropediatric department, Ghent University Hospital, Ghent, Belgium.
Centre for Developmental disorders, University Hospital Ghent, Ghent, Belgium.

Beth A Pletcher (BA)

Department of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

David Ros-Pardo (D)

Molecular Modeling Group, Centro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), Madrid, Spain.

Shanika Samarasekera (S)

Neurology Department, Queen Elizabeth Hospital, Birmingham, UK.

Marco Tartaglia (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.

Kristof Van Schil (K)

Department of Medical Genetics, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

Julie Vogt (J)

West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital, Birmingham, UK.

Evangeline Wassmer (E)

Neurology Department, Birmingham Women and Children's Hospital, Birmingham, UK.
Institute of Health and Neurodevelopment, Aston University, Birmingham, UK.

Juliane Winkelmann (J)

Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Maha S Zaki (MS)

Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Genetics Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt.

Michael Zech (M)

Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Holger Lerche (H)

Department of Neurology and Epileptology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Francesca Clementina Radio (FC)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.

Paulino Gomez-Puertas (P)

Molecular Modeling Group, Centro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), Madrid, Spain.

Rikke S Møller (RS)

Department of Epilepsy Genetics and Personalized Treatment, The Danish Epilepsy Centre, Dianalund, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Zeynep Tümer (Z)

Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH